IBEX Limited Reports Strong Q3 FY 2026 Earnings Growth
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 23 hours ago
0mins
Should l Buy IBEX?
Source: seekingalpha
- Significant Revenue Growth: IBEX reported a revenue of $164.4 million for Q3 FY 2026, marking a 17% increase, driven by strong performance in the health tech sector, which is expected to exceed $100 million in annual revenue, thereby solidifying its market position.
- Excellent Client Retention: The company achieved a 100% client retention rate for the quarter and a 99.9% revenue retention rate for the year, reflecting enhanced customer satisfaction and laying a solid foundation for future growth.
- Upgraded Financial Outlook: Management raised the FY 2026 revenue guidance to a range of $638 million to $642 million, up from $620 million to $630 million, indicating strong confidence in future performance and robust market demand.
- Strategic Partnership: The partnership with Sierra ai is viewed as central to “BPO 3.0,” and while there are risks of AI potentially cannibalizing some business, management believes it will positively impact revenue and enhance overall profit margins.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy IBEX?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on IBEX
Wall Street analysts forecast IBEX stock price to rise
2 Analyst Rating
0 Buy
2 Hold
0 Sell
Hold
Current: 28.110
Low
40.00
Averages
41.00
High
42.00
Current: 28.110
Low
40.00
Averages
41.00
High
42.00
About IBEX
IBEX Limited is a provider of global business process outsourcing and end-to-end customer engagement technology solutions. The Company helps brands effectively engage their customers with services ranging from customer support, technical support, inbound/outbound sales, business intelligence and analytics, digital demand generation, and customer experience (CX) surveys and feedback analytics. Through the Company’s integrated customer lifecycle experience (CLX) platform, a comprehensive portfolio of solutions is offered to help optimize customer acquisition, engagement, expansion and experience for clients. The Company leverages advanced technology and proprietary analytics, in combination with its global footprint and business process outsourcing expertise, to protect and enhance clients’ brands. Its services cover three areas: Digital & Omni-Channel Customer Experience (ibex Connect), Digital Marketing and E-Commerce (ibex Digital) and Digital CX surveys and analytics (ibex CX).
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
IBEX Limited Reports Strong Q3 FY 2026 Earnings Growth
- Significant Revenue Growth: IBEX reported a revenue of $164.4 million for Q3 FY 2026, marking a 17% increase, driven by strong performance in the health tech sector, which is expected to exceed $100 million in annual revenue, thereby solidifying its market position.
- Excellent Client Retention: The company achieved a 100% client retention rate for the quarter and a 99.9% revenue retention rate for the year, reflecting enhanced customer satisfaction and laying a solid foundation for future growth.
- Upgraded Financial Outlook: Management raised the FY 2026 revenue guidance to a range of $638 million to $642 million, up from $620 million to $630 million, indicating strong confidence in future performance and robust market demand.
- Strategic Partnership: The partnership with Sierra ai is viewed as central to “BPO 3.0,” and while there are risks of AI potentially cannibalizing some business, management believes it will positively impact revenue and enhance overall profit margins.
See More
Ibex (IBEX) Q3 2026 Earnings Call Transcript
See More
IBEX Holdings Q3 Earnings Exceed Expectations
- Earnings Beat: IBEX Holdings reported a Q3 Non-GAAP EPS of $0.91, exceeding expectations by $0.06, indicating strong performance in the healthtech sector and boosting investor confidence.
- Significant Revenue Growth: The company achieved Q3 revenue of $164.4 million, a 16.8% year-over-year increase, surpassing market expectations by $8.54 million, reflecting sustained demand in higher-margin regions.
- Upgraded Revenue Guidance: IBEX raised its FY26 revenue guidance to a range of $638 to $642 million, up from $620 to $630 million, signaling optimism about future growth prospects.
- Increased Capital Expenditures: Capital expenditures are now expected to be between $25 million and $30 million, up from the previous range of $20 million to $25 million, driven by ongoing investments to meet rising demand in high-margin areas, highlighting the company's commitment to future growth.
See More
IBEX Holdings Set to Announce Q3 Earnings with Positive Estimates
- Earnings Announcement: IBEX Holdings is set to release its Q3 earnings on May 6, with consensus EPS estimates at $0.85, reflecting a 3.7% year-over-year growth, indicating stable profitability.
- Revenue Growth Expectations: The anticipated revenue for Q3 stands at $155.86 million, representing a 10.8% year-over-year increase, showcasing the company's ongoing growth in the health tech sector and rising market demand.
- Historical Performance: Over the past two years, IBEX has surpassed EPS and revenue estimates 88% of the time, demonstrating reliability in financial performance and bolstering investor confidence.
- Revision Trends: In the last three months, EPS estimates saw no upward revisions but two downward adjustments, while revenue estimates experienced two upward revisions, reflecting a positive market sentiment towards IBEX's future growth.
See More
ibex Achieves ISO/IEC 42001 Certification for AI Governance
- Certification Achievement: ibex has achieved ISO/IEC 42001 certification after a rigorous two-stage audit, validating its responsible governance in the design, development, and operation of AI-powered customer experience solutions, thereby reinforcing its leadership position in the industry.
- Risk Management Framework: This certification ensures that ibex has implemented comprehensive governance and risk management processes regarding ethics, bias, security, and transparency in its AI technologies, enhancing client trust and security in its AI systems.
- Cybersecurity Leadership: ibex ranks first in SecurityScorecard's cybersecurity ranking with a perfect score of 100, demonstrating its strong cyber posture and further boosting client confidence in data protection.
- Ongoing Investment: By combining responsible AI governance with industry-leading cybersecurity practices, ibex continues to invest in infrastructure and technology to deliver trusted AI-powered customer engagement solutions that meet the needs of top global brands.
See More
IBEX Limited Reports Exceptional Q2 2026 Earnings Growth
- Significant Earnings Growth: IBEX reported Q2 revenue of $164.2 million, a 16.7% increase year-over-year, with adjusted EPS rising by 46%, showcasing the company's strong performance in HealthTech and FinTech, which solidifies its market position.
- Rapid Rise of HealthTech: The HealthTech segment saw a 35.1% revenue increase, with projections to exceed $100 million by the fiscal year-end, indicating that IBEX's strategic investments in high-growth areas are yielding results and enhancing future profitability.
- Expansion into India: The company has established two operational centers in India with nearly 1,000 agents, offering revenue cycle management and credentialing services for healthcare clients, demonstrating IBEX's growth potential and market penetration in emerging markets.
- AI Leadership Position: IBEX is ahead of competitors in AI solutions, with the CEO emphasizing the enhancement of customer service and internal efficiency through the Wave iX AI solution, further driving the company's transition to an AI-first operational model and strengthening its long-term competitive advantage.
See More
IBEX Limited Reports Strong Q3 FY 2026 Earnings Growth
- Significant Revenue Growth: IBEX reported a revenue of $164.4 million for Q3 FY 2026, marking a 17% increase, driven by strong performance in the health tech sector, which is expected to exceed $100 million in annual revenue, thereby solidifying its market position.
- Excellent Client Retention: The company achieved a 100% client retention rate for the quarter and a 99.9% revenue retention rate for the year, reflecting enhanced customer satisfaction and laying a solid foundation for future growth.
- Upgraded Financial Outlook: Management raised the FY 2026 revenue guidance to a range of $638 million to $642 million, up from $620 million to $630 million, indicating strong confidence in future performance and robust market demand.
- Strategic Partnership: The partnership with Sierra ai is viewed as central to “BPO 3.0,” and while there are risks of AI potentially cannibalizing some business, management believes it will positively impact revenue and enhance overall profit margins.
See More
Ibex (IBEX) Q3 2026 Earnings Call Transcript
See More
IBEX Holdings Q3 Earnings Exceed Expectations
- Earnings Beat: IBEX Holdings reported a Q3 Non-GAAP EPS of $0.91, exceeding expectations by $0.06, indicating strong performance in the healthtech sector and boosting investor confidence.
- Significant Revenue Growth: The company achieved Q3 revenue of $164.4 million, a 16.8% year-over-year increase, surpassing market expectations by $8.54 million, reflecting sustained demand in higher-margin regions.
- Upgraded Revenue Guidance: IBEX raised its FY26 revenue guidance to a range of $638 to $642 million, up from $620 to $630 million, signaling optimism about future growth prospects.
- Increased Capital Expenditures: Capital expenditures are now expected to be between $25 million and $30 million, up from the previous range of $20 million to $25 million, driven by ongoing investments to meet rising demand in high-margin areas, highlighting the company's commitment to future growth.
See More
IBEX Holdings Set to Announce Q3 Earnings with Positive Estimates
- Earnings Announcement: IBEX Holdings is set to release its Q3 earnings on May 6, with consensus EPS estimates at $0.85, reflecting a 3.7% year-over-year growth, indicating stable profitability.
- Revenue Growth Expectations: The anticipated revenue for Q3 stands at $155.86 million, representing a 10.8% year-over-year increase, showcasing the company's ongoing growth in the health tech sector and rising market demand.
- Historical Performance: Over the past two years, IBEX has surpassed EPS and revenue estimates 88% of the time, demonstrating reliability in financial performance and bolstering investor confidence.
- Revision Trends: In the last three months, EPS estimates saw no upward revisions but two downward adjustments, while revenue estimates experienced two upward revisions, reflecting a positive market sentiment towards IBEX's future growth.
See More
ibex Achieves ISO/IEC 42001 Certification for AI Governance
- Certification Achievement: ibex has achieved ISO/IEC 42001 certification after a rigorous two-stage audit, validating its responsible governance in the design, development, and operation of AI-powered customer experience solutions, thereby reinforcing its leadership position in the industry.
- Risk Management Framework: This certification ensures that ibex has implemented comprehensive governance and risk management processes regarding ethics, bias, security, and transparency in its AI technologies, enhancing client trust and security in its AI systems.
- Cybersecurity Leadership: ibex ranks first in SecurityScorecard's cybersecurity ranking with a perfect score of 100, demonstrating its strong cyber posture and further boosting client confidence in data protection.
- Ongoing Investment: By combining responsible AI governance with industry-leading cybersecurity practices, ibex continues to invest in infrastructure and technology to deliver trusted AI-powered customer engagement solutions that meet the needs of top global brands.
See More
IBEX Limited Reports Exceptional Q2 2026 Earnings Growth
- Significant Earnings Growth: IBEX reported Q2 revenue of $164.2 million, a 16.7% increase year-over-year, with adjusted EPS rising by 46%, showcasing the company's strong performance in HealthTech and FinTech, which solidifies its market position.
- Rapid Rise of HealthTech: The HealthTech segment saw a 35.1% revenue increase, with projections to exceed $100 million by the fiscal year-end, indicating that IBEX's strategic investments in high-growth areas are yielding results and enhancing future profitability.
- Expansion into India: The company has established two operational centers in India with nearly 1,000 agents, offering revenue cycle management and credentialing services for healthcare clients, demonstrating IBEX's growth potential and market penetration in emerging markets.
- AI Leadership Position: IBEX is ahead of competitors in AI solutions, with the CEO emphasizing the enhancement of customer service and internal efficiency through the Wave iX AI solution, further driving the company's transition to an AI-first operational model and strengthening its long-term competitive advantage.
See More
